Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021
The global non-invasive prenatal testing (NIPT) market is projected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.
By product, the non-invasive prenatal testing market is segmented into consumables and instruments. In 2016, the consumables segment accounted for the largest share of the market. The high demand due to the recurring requirement of consumables as compared to instruments is a key driver for the growth of this product segment.
On the basis of method, the market is segmented into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests. The ultrasound detection segment dominated the market in 2016. However, the cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR. This is mainly attributed to the increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services.
On the basis of application, the market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy commands the largest and fastest-growing application segment of the global market in 2016. This is attributed to factors such as increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, the market is classified into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the rising incidence of chromosomal abnormalities and increasing initiatives by companies to provide advanced equipment to diagnostic laboratories.
North America commanded the largest share of the global market in 2016. Asia is expected to grow at the highest CAGR during the forecast period. The high growth in the Asian market is attributed to increasing disposable income, rising healthcare infrastructure, rising awareness programs and conferences, and increasing focus of market players in this region. Some prominent markets in Asia include China, India, and Japan.
This market is categorized on the basis of product, method, application, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of top players in the NIPT market. The report analyzes the non-invasive prenatal testing market by product, method, application, end user, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the NIPT market.
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the NIPT market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for NIPT across geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the NIPT market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook